• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 合并 2 型糖尿病患者的细胞因子谱和免疫应答增强。

The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.

机构信息

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.

出版信息

J Diabetes Res. 2021 Jan 2;2021:9526701. doi: 10.1155/2021/9526701. eCollection 2021.

DOI:10.1155/2021/9526701
PMID:33490288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7796849/
Abstract

The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mellitus (NDM) group, impaired fasting glucose (IFG) group, and diabetes mellitus (DM) group. The average hospitalization days were significantly shorter in DM patients when compared with patients in the IFG group and NDM group. CD4 T cell percentage was higher while CD8 T cells percentage was lower in the DM group than those in the NDM group. The serum levels of IL-6, IL-2, IL-10, and INF- in the DM group were upregulated when compared with those in the NDM group. The serum levels of TNF-, IL-4, IL-2, IL-10, and INF- were significantly higher in the DM group than those in the IFG group. A significant difference was observed in CD4 T cell, CD4/CD8 ratio percentage, IL-6, and IL-10 between the NDM group and DM group with adjusted BMI. In conclusion, COVID-19 patients with elevated glucose levels have promoted cytokine profiles and immune response.

摘要

炎症和细胞因子风暴的诱导被认为在 COVID-19 中发挥关键作用。本研究旨在探讨 COVID-19 住院患者葡萄糖代谢与炎症状态之间的关系。71 例 COVID-19 住院患者分为非糖尿病(NDM)组、空腹血糖受损(IFG)组和糖尿病(DM)组。与 IFG 组和 NDM 组相比,DM 组患者的平均住院天数明显缩短。DM 组 CD4 T 细胞百分比高于 NDM 组,CD8 T 细胞百分比低于 NDM 组。与 NDM 组相比,DM 组血清中 IL-6、IL-2、IL-10 和 INF-的水平上调。与 IFG 组相比,DM 组血清中 TNF-α、IL-4、IL-2、IL-10 和 INF-的水平显著升高。在调整 BMI 后,NDM 组和 DM 组之间的 CD4 T 细胞、CD4/CD8 比值百分比、IL-6 和 IL-10 存在显著差异。结论:血糖水平升高的 COVID-19 患者具有促进细胞因子谱和免疫反应的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b8/7796849/ccc1b9d5565e/JDR2021-9526701.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b8/7796849/ccc1b9d5565e/JDR2021-9526701.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b8/7796849/ccc1b9d5565e/JDR2021-9526701.001.jpg

相似文献

1
The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.COVID-19 合并 2 型糖尿病患者的细胞因子谱和免疫应答增强。
J Diabetes Res. 2021 Jan 2;2021:9526701. doi: 10.1155/2021/9526701. eCollection 2021.
2
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.COVID-19 进展中血清学变化下 T 淋巴细胞减少和耗竭特征及预后因素。
Mol Immunol. 2021 Oct;138:121-127. doi: 10.1016/j.molimm.2021.06.001. Epub 2021 Aug 6.
3
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.新型冠状病毒肺炎患者 2 型糖尿病的免疫学特征。
Front Endocrinol (Lausanne). 2021 Mar 11;12:596518. doi: 10.3389/fendo.2021.596518. eCollection 2021.
4
Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.COVID-19 康复患者的循环细胞因子和淋巴细胞亚群。
Biomed Res Int. 2020 Nov 26;2020:7570981. doi: 10.1155/2020/7570981. eCollection 2020.
5
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.原发感染 6 个月后仍能保持对 SARS-CoV-2 的特异性 T 细胞免疫。
Nat Immunol. 2021 May;22(5):620-626. doi: 10.1038/s41590-021-00902-8. Epub 2021 Mar 5.
6
Mild Cytokine Elevation, Moderate CD4 T Cell Response and Abundant Antibody Production in Children with COVID-19.儿童 COVID-19 患者表现为轻度细胞因子升高、中度 CD4+T 细胞应答和丰富的抗体产生。
Virol Sin. 2020 Dec;35(6):734-743. doi: 10.1007/s12250-020-00265-8. Epub 2020 Jul 22.
7
The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.与疾病严重程度相关的炎症因子预测COVID-19病情进展
J Immunol. 2021 Apr 1;206(7):1597-1608. doi: 10.4049/jimmunol.2001327. Epub 2021 Feb 12.
8
Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.与非糖尿病个体相比,合并 2 型糖尿病的 COVID-19 患者具有明显不同的免疫特征。
Mediators Inflamm. 2020 Sep 29;2020:6914878. doi: 10.1155/2020/6914878. eCollection 2020.
9
Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.解析 COVID-19 细胞因子风暴:系统评价和荟萃分析。
Eur J Clin Invest. 2021 Jan;51(1):e13429. doi: 10.1111/eci.13429. Epub 2020 Nov 2.
10
Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.2 型糖尿病与肺结核中 CD8(+) T 细胞和自然杀伤细胞功能改变有关。
Immunology. 2015 Apr;144(4):677-86. doi: 10.1111/imm.12421.

引用本文的文献

1
Diabetes Mellitus, a Leading Comorbidity in COVID-19: an Insight on Pathophysiology, Molecular Interactions, and Comprehensive Management.糖尿病,COVID-19中的主要合并症:对病理生理学、分子相互作用及综合管理的见解
Curr Microbiol. 2025 Jul 16;82(9):388. doi: 10.1007/s00284-025-04369-w.
2
The relationship of age, sex and prothrombin time related to the severity of COVID-19 patients with diabetes mellitus: a systematic review and meta analysis.年龄、性别和凝血酶原时间与糖尿病合并COVID-19患者严重程度的关系:一项系统评价和荟萃分析
F1000Res. 2024 Aug 8;11:729. doi: 10.12688/f1000research.107398.3. eCollection 2022.
3

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Metformin and COVID-19: From cellular mechanisms to reduced mortality.二甲双胍与 COVID-19:从细胞机制到降低死亡率。
Diabetes Metab. 2020 Nov;46(6):423-426. doi: 10.1016/j.diabet.2020.07.006. Epub 2020 Aug 1.
3
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.
草药作为管理2型糖尿病合并新冠患者并发症的辅助疗法
Diabetes Metab Syndr Obes. 2025 Jan 16;18:135-146. doi: 10.2147/DMSO.S498774. eCollection 2025.
4
Memory T Cells Discrepancies in COVID-19 Patients.新冠患者体内记忆T细胞的差异
Microorganisms. 2023 Nov 9;11(11):2737. doi: 10.3390/microorganisms11112737.
5
SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation.SARS-CoV-2 刺突蛋白通过肾素-血管紧张素-醛固酮系统和 TLR 信号激活加剧糖尿病 hACE2 小鼠的脑血管并发症。
Int J Mol Sci. 2023 Nov 16;24(22):16394. doi: 10.3390/ijms242216394.
6
Topic Modeling Analysis of Diabetes-Related Health Information during the Coronavirus Disease Pandemic.冠状病毒病大流行期间糖尿病相关健康信息的主题建模分析
Healthcare (Basel). 2023 Jun 27;11(13):1871. doi: 10.3390/healthcare11131871.
7
Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study.高血糖对 2 型糖尿病合并 COVID-19 患者免疫功能的影响:一项回顾性研究。
PeerJ. 2022 Dec 16;10:e14570. doi: 10.7717/peerj.14570. eCollection 2022.
8
T Cell Response to SARS-CoV-2 Coinfection and Comorbidities.T细胞对SARS-CoV-2合并感染及合并症的反应。
Pathogens. 2023 Feb 15;12(2):321. doi: 10.3390/pathogens12020321.
9
Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity.肥胖2型糖尿病个体的白细胞代谢与新冠病毒疾病严重程度相关。
Front Microbiol. 2022 Nov 3;13:1037469. doi: 10.3389/fmicb.2022.1037469. eCollection 2022.
10
Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases.用于确定新型冠状病毒感染对人类自身免疫性疾病进展影响的系统生物学模型。
Inform Med Unlocked. 2022;32:101003. doi: 10.1016/j.imu.2022.101003. Epub 2022 Jul 6.
COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
4
Prevalence and impact of diabetes among people infected with SARS-CoV-2.2019冠状病毒病感染者中糖尿病的患病率及影响
J Endocrinol Invest. 2020 Jun;43(6):867-869. doi: 10.1007/s40618-020-01236-2. Epub 2020 Mar 28.
5
COVID-19 infection: the perspectives on immune responses.新型冠状病毒肺炎感染:免疫反应的观点
Cell Death Differ. 2020 May;27(5):1451-1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.2019年新型冠状病毒病(COVID-19)疫情期间急需及时进行血糖管理。
Diabetes Res Clin Pract. 2020 Apr;162:108118. doi: 10.1016/j.diabres.2020.108118. Epub 2020 Mar 13.
8
Clinical progression of patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者的临床进展。
J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.